SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001654954-21-012022
Filing Date
2021-11-12
Accepted
2021-11-12 08:04:34
Documents
43
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT mnpr_10q.htm   iXBRL 10-Q 747525
2 CERTIFICATION OF CHANDLER D. ROBINSON, CHIEF EXECUTIVE OFFICER mnpr_ex311.htm EX-31.1 12174
3 CERTIFICATION OF KIM R. TSUCHIMOTO, CHIEF FINANCIAL OFFICER mnpr_ex312.htm EX-31.2 12543
4 CERTIFICATION OF CHANDLER D. ROBINSON, CHIEF EXECUTIVE OFFICER AND KIM R. TSUCHI mnpr_ex321.htm EX-32.1 6245
5 IMAGE mnpr_10qimg10.jpg GRAPHIC 21238
  Complete submission text file 0001654954-21-012022.txt   3068335

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA mnpr-20210930.xsd EX-101.SCH 31909
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE mnpr-20210930_cal.xml EX-101.CAL 25288
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mnpr-20210930_def.xml EX-101.DEF 83257
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE mnpr-20210930_lab.xml EX-101.LAB 203449
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mnpr-20210930_pre.xml EX-101.PRE 155897
11 EXTRACTED XBRL INSTANCE DOCUMENT mnpr_10q_htm.xml XML 412150
Mailing Address 1000 SKOKIE BLVD SUITE 350 WILMETTE IL 60091
Business Address 1000 SKOKIE BLVD SUITE 350 WILMETTE IL 60091 8473880349
Monopar Therapeutics (Filer) CIK: 0001645469 (see all company filings)

IRS No.: 320463781 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39070 | Film No.: 211399742
SIC: 2834 Pharmaceutical Preparations